Related Experiment Video

Updated: Sep 20, 2026

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
11:02

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

cIAP-2 block apoptotic events in bladder cancer cells

Gun Jönsson1, Staffan Paulie, Alf Grandien

  • 1Department of Immunology, Wenner-Gren Institute, Stockholm University, S-106 91 Stockholm, Sweden. gun@imm2.su.se

Anticancer Research
|August 21, 2003
PubMed
Abstract

Insights

Inhibitors of Apoptosis (IAPs) like cIAP-2 regulate cell death in bladder cancer. Overexpression of cIAP-2 promotes resistance to apoptosis, but combination therapies show promise against resistant tumors.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Death Research

Background:

  • Inhibitors of Apoptosis (IAPs) are key negative regulators of programmed cell death (apoptosis).
  • Overexpression of IAPs contributes to cellular resistance against various apoptotic triggers.
  • Investigated IAP mRNA expression in bladder tumor cells exhibiting differential sensitivity to apoptosis.

Purpose of the Study:

  • To examine the role of IAP mRNA expression in bladder tumor cell apoptosis.
  • To determine the correlation between specific IAP expression and resistance to death receptor-mediated apoptosis.
  • To evaluate the therapeutic implications of IAP modulation in bladder cancer.

Main Methods:

  • Quantified IAP mRNA expression using Ribonuclease Protection Assay (RPA).
  • Induced apoptosis via recombinant killerTRAIL, anti-CD95 agonistic monoclonal antibodies (mAbs), or doxorubicin.
  • Assessed apoptosis using TUNEL and MTT assays; achieved stable cIAP-2 expression via retroviral transduction.

Main Results:

  • High cIAP-2 mRNA expression strongly correlated with resistance to TRAIL-induced apoptosis.
  • cIAP-2 overexpression conferred resistance to apoptosis in previously sensitive bladder cancer cell lines.
  • Combined treatment with doxorubicin and TRAIL or anti-CD95 showed synergistic cytotoxicity, unaffected by cIAP-2 overexpression.

Conclusions:

  • cIAP-2 is a critical regulator of apoptosis in bladder cancer.
  • Elevated cIAP-2 levels can reduce tumor susceptibility to apoptosis-inducing therapies.
  • Combination therapy involving immunotherapy and chemotherapy offers a potent strategy against resistant bladder tumors.

More Related Videos

Evaluation of the Efficacy of the H. pylori Protein HP-NAP as a Therapeutic Tool for Treatment of Bladder Cancer in an Orthotopic Murine Model06:12

Evaluation of the Efficacy of the H. pylori Protein HP-NAP as a Therapeutic Tool for Treatment of Bladder Cancer in an Orthotopic Murine Model

Published on: May 29, 2015

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...